Skip to main content
. 2020 Jul 23;8:851. doi: 10.3389/fbioe.2020.00851

TABLE 2.

Bioprocess features selected by each surrogate modeling technique from Feature Set 2 (X = selected).

Feature FS2-RF FS2-GPR FS2-MARS
Average DO concentration d0 X
Average DO concentration dd0 X
Average DO concentration dd2 X
Average DO concentration dd4 X
Average DO concentration gradient d0 X
Average DO concentration gradient dd2 X X
Average DO concentration gradient dd4 X X
Average DO concentration gradient dd5 X
d1 average pH gradient X
dd0 aggregate size X
dd0 cell density X
dd0–dd1 cell density gradient X
dd1 average pH X X
dd1 average acceleration of cell density normalized DO gradient X
dd2 aggregate size X
dd2 average acceleration of DO gradient X
dd2 average pH X
dd2 average pH gradient X
dd2 average acceleration of cell density normalized DO gradient X
dd2–dd3 aggregate size gradient X
dd3–dd5 cell density gradient X
dd4 average pH gradient X
dd5 average acceleration of cell density normalized DO gradient X X
Cell density normalized DO concentration dd1 X
Average cell density normalized DO concentration gradient dd5 X
IWP2 treatment time [h] X X
Overall aggregate size gradient X
Overall density gradient X